PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats

scientific article

PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1152/AJPREGU.1998.274.1.R23
P698PubMed publication ID9458894

P2093author name stringWellman PJ
McMahon LR
P433issue1 Pt 2
P407language of work or nameEnglishQ1860
P304page(s)R23-9
P577publication date1998-01-01
P1433published inAmerican Journal of PhysiologyQ2160146
P1476titlePVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats
P478volume274

Reverse relations

cites work (P2860)
Q47736265A Vitamin B12 Conjugate of Exendin-4 Improves Glucose Tolerance Without Associated Nausea or Hypophagia in Rodents.
Q30352488Activation of murine pre-proglucagon-producing neurons reduces food intake and body weight.
Q36807579Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake
Q36718656Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance.
Q37174896CNS GLP-1 regulation of peripheral glucose homeostasis
Q44516249CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors.
Q36796571Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation
Q39146023Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides
Q36979763Central control of body weight and appetite
Q36953564Characterization of apolipoprotein A-IV in brain areas involved in energy homeostasis
Q39419249Characterizing ingestive behavior through licking microstructure: Underlying neurobiology and its use in the study of obesity in animal models
Q88924595Endocannabinoids in Body Weight Control
Q39249139Endogenous Glucagon-like Peptide-1 Receptor Signaling in the Nucleus Tractus Solitarius is Required for Food Intake Control
Q45070671Enhanced AMPA Receptor Trafficking Mediates the Anorexigenic Effect of Endogenous Glucagon-like Peptide-1 in the Paraventricular Hypothalamus
Q35948898Exendin-4 decreases amphetamine-induced locomotor activity
Q41449397Exogenous glucagon-like peptide-1 acts in sites supplied by the cranial mesenteric artery to reduce meal size and prolong the intermeal interval in rats
Q34745109Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain.
Q36474058Feeding and the rhodopsin family g-protein coupled receptors in nematodes and arthropods
Q37885717GLP-1 and energy balance: an integrated model of short-term and long-term control
Q38794234GLP-1 and weight loss: unraveling the diverse neural circuitry
Q35200252GLP-1 based therapeutics: simultaneously combating T2DM and obesity.
Q35744558GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake
Q27000749GLP-1, the gut-brain, and brain-periphery axes
Q90016044GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Q48325811Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons
Q41816012Glucagon-like Peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed
Q35893496Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake
Q37224352Glucagon-like peptide-1 receptor agonist administration suppresses both water and saline intake in rats.
Q35601526Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake
Q33911780Glucagon-like peptide-1 reduces pancreatic β-cell mass through hypothalamic neural pathways in high-fat diet-induced obese rats
Q36452530Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism
Q37054716High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.
Q37142459Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt.
Q33901243Hindbrain oxytocin receptors contribute to the effects of circulating oxytocin on food intake in male rats
Q35647295Hippocampal GLP-1 receptors influence food intake, meal size, and effort-based responding for food through volume transmission
Q38629710Hippocampus Contributions to Food Intake Control: Mnemonic, Neuroanatomical, and Endocrine Mechanisms
Q37892968Hypothalamic control of energy and glucose metabolism
Q35690970Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose
Q35024826Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation
Q88732200Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons
Q28072517Microbial regulation of GLP-1 and L-cell biology
Q37244738Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis.
Q26826926Moving beyond energy homeostasis: new roles for glucagon-like peptide-1 in food and drug reward
Q38197775Neural integration of satiation and food reward: role of GLP-1 and orexin pathways.
Q36339320PPG neurons of the lower brain stem and their role in brain GLP-1 receptor activation.
Q40443483Parabrachial Nucleus Contributions to Glucagon-Like Peptide-1 Receptor Agonist-Induced Hypophagia
Q35110843Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
Q48344210Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia.
Q36955246Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice
Q37219033Pharmacologically Counteracting a Phenotypic Difference in Cerebellar GABAA Receptor Response to Alcohol Prevents Excessive Alcohol Consumption in a High Alcohol-Consuming Rodent Genotype
Q59812434Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Q37139700Role of lateral septum glucagon-like peptide 1 receptors in food intake
Q34425122Role of oxytocin signaling in the regulation of body weight
Q42737933Satiation and stress-induced hypophagia: examining the role of hindbrain neurons expressing prolactin-releasing Peptide or glucagon-like Peptide 1.
Q36469127Sex and estrogens alter the action of glucagon-like peptide-1 on reward
Q93367537The Functional and Neurobiological Properties of Bad Taste
Q38850561The Gut as an Endocrine Organ: Role in the Regulation of Food Intake and Body Weight
Q26799942The L-Cell in Nutritional Sensing and the Regulation of Appetite
Q28484398The anorectic effect of GLP-1 in rats is nutrient dependent
Q30596646The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Q21129358The central GLP-1: implications for food and drug reward
Q28216072The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness
Q37343491The effects of GLP-1 infusion in the hepatic portal region on food intake
Q47996706The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.
Q35035127The glucagon-like peptide 1 analogue Exendin-4 attenuates the nicotine-induced locomotor stimulation, accumbal dopamine release, conditioned place preference as well as the expression of locomotor sensitization in mice
Q28534678The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice
Q28598004The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents
Q34621785The gut and food intake: an update for surgeons.
Q41718186The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.

Search more.